← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Leuprorelin acetat currently has availability issues reported in 3 European registers: Austria, Greece, Sweden.
Limited availability ATC L02AE02 · also listed as: LEUPRORELIN ACETAT · LEUPRORELIN ACETATE · leuprorelinacetat · data refreshed 11 September 2026
As of 11 September 2026, 3 of the 9 tracked registers list current availability issues for Leuprorelin acetat, covering 6 affected product presentations. The longest-running open report was filed in Greece on 2025-11-27 and has now been open for about 10 months. Where agencies state a cause, delivery delays lead with 1 of the 1 stated-cause reports. Notably, 3 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Greece reported first (2025-11-27), with Sweden following roughly 9 months later — a pattern typical of supply problems cascading between national markets. Registers in Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Leuprorelin acetat is coded L02AE02 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Enantone Monats-Depot - Zweikammerspritze + 2 more productsEnantone-Gyn Monats-Depot - Zweikammerspritze Trenantone - Zweikammerspritze | 2026-06-05 | — | — | register ↗ |
| 🇬🇷 Greece | Limited availability BTX1 VIAL+1 AMPX2 ML | 2025-11-27 | 2026-09-07 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευάσματα της | register ↗ |
| 🇸🇪 Sweden | Expected shortage Enanton Depot Dual 11,25 mg Pulv och vätska t inj.vätska, susp. i förf. spruta + 1 more productsEnanton Depot Dual 30 mg Pulv och vätska t inj.vätska, susp. i förf. spruta | 2026-08-03 | 2026-09-01 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Leuprorelin acetat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Enanton Depot Dual 11,25 mg Pulv och vätska t inj.vätska, susp. i förf | Expected shortage | 2026-08-03 | 2026-09-01 | |
| 🇸🇪 SE | Enanton Depot Dual 30 mg Pulv och vätska t inj.vätska, susp. i förf. s | Expected shortage | 2026-08-03 | 2026-09-01 | |
| 🇦🇹 AT | Enantone Monats-Depot - Zweikammerspritze | Limited availability | 2026-06-05 | — | |
| 🇦🇹 AT | Enantone-Gyn Monats-Depot - Zweikammerspritze | Limited availability | 2026-06-05 | — | |
| 🇦🇹 AT | Trenantone - Zweikammerspritze | Limited availability | 2026-06-05 | — | |
| 🇬🇷 GR | BTX1 VIAL+1 AMPX2 ML | Limited availability | 2025-11-27 | 2026-09-07 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
Yes. As of 11 September 2026, availability issues are reported in: Austria, Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Leuprorelin acetat: BASG (Austria), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Leuprorelin acetat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/leuprorelin-acetat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Leuprorelin acetat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/leuprorelin-acetat/">Leuprorelin acetat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>